NGNENeurogene, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 19152
Ticker: NGNE
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2023-12-19
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: NGNE

Detail

Enriched 2026-08-14 20:47

Market cap: $740,020,906.36
Shares outstanding (class): 15,801,901
Shares outstanding (weighted): 20,011,382
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 131
Location: NEW YORK, NY
Homepage: https://www.neurogene.com
Description: Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Market cap and share counts drift.

Funds holding this security

65 funds · 66 positions · $29.59M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$7.70M	0.00%	382,191 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$5.45M	0.01%	270,461 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$2.43M	0.00%	120,532 NS	FIGI
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$2.04M	0.09%	101,075 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$1.94M	0.02%	96,438 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$1.91M	0.02%	94,694 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$1.57M	0.04%	77,849 NS	FIGI
Meridian Small Cap Growth Fund Meridian Fund Inc	—	$1.53M	0.65%	75,859 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$729.8K	0.07%	36,199 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$573.0K	0.05%	28,425 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$378.6K	0.31%	18,781 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$339.3K	0.01%	16,828 NS	FIGI
JPMorgan U.S. Small Company Fund JPMorgan Trust I	—	$335.0K	0.04%	16,617 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$281.7K	0.02%	13,972 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$239.8K	0.01%	11,896 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERNGNE
FIGI_COMPOSITEBBG005Y0QDK1
FIGI_SHARE_CLASSBBG005Y0QF99
CIK0001404644
ISINUS64135M1053
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Neurogene is a biopharmaceutical company developing gene therapies, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.